Resources

Monitoring of suicidal ideation and suicide attempts during COVID‑19 from the Emergency Management Information System

Product: — Institut national de santé publique du Québec

Ethics & Socio-cultural Mental Health & Well-being Mental Wellness Urgent Care Vulnerable Sub-populations

www.inspq.qc.ca Last Updated: March 30, 2022

Also available in Français

Mitigating the Impacts of the COVID‑19 Pandemic on the Development of Children Aged 0 to 5: Adapting Public Health Practices to Families and in Living Environments

Product: — Institut national de santé publique du Québec

Barriers to Access Community Prevention & Transmission Ethics & Socio-cultural Public Health & Implementation Social Compliance Vulnerable Sub-populations

www.inspq.qc.ca Last Updated: March 28, 2022

Also available in Français

COVID-19: Promoting Mental Health and Well-Being Through Community Resilience and Social Cohesion

Product: — Institut national de santé publique du Québec

Health Equity & Social Determinants of Health Mental Health & Well-being Mental Wellness Recreation Recreation Grounds Socio-cultural

www.inspq.qc.ca Last Updated: March 17, 2022

Also available in Français

Measures to Mitigate the Effects of the Pandemic on Food Insecurity

Product: — Institut national de santé publique du Québec

Barriers to Access Cost Economics Health Equity & Social Determinants of Health Health Inequities Socio-cultural

www.inspq.qc.ca Last Updated: March 16, 2022

Also available in Français

COVID-19: Indigenous resilience, a lever to support

Product: — Institut national de santé publique du Québec

Community Prevention & Transmission Ethics & Socio-cultural Health Equity & Social Determinants of Health Socio-cultural Transmission Vulnerable Sub-populations

www.inspq.qc.ca Last Updated: March 16, 2022

Also available in Français

Clinical Practice Guideline Summary: Recommended Drugs and Biologics in Adult Patients with COVID-19

Product: — Science Table

Drug Interventions Infectious Diseases & Clinical Care Practice Guidelines Treatments

covid19-sciencetable.ca Last Updated: February 23, 2022

Nirmatrelvir/Ritonavir (Paxlovid): What Prescribers and Pharmacists Need to Know

Product: — Science Table

Drug Interventions Infectious Diseases & Clinical Care Practice Guidelines Treatments

covid19-sciencetable.ca Last Updated: February 23, 2022

Update on COVID‑19 Projections: Additional Modelling on Booster Doses

Product: — Science Table

Community Prevention & Transmission Epidemiology Vaccine Vaccines & Immunity

covid19-sciencetable.ca Last Updated: February 8, 2022

CADTH Custom Request: Impacts of COVID‑19 on First Nations, Inuit, and Métis Populations in Canada

Product: — Canadian Agency for Drugs and Technologies in Health

Ethics & Socio-cultural Socio-cultural Vulnerable Groups Vulnerable Sub-populations

covid.cadth.ca Last Updated: January 28, 2022

Also available in Français

Clinical Practice Guideline Summary: Recommended Drugs and Biologics in Adult Patients with COVID-19

Product: — Science Table

Drug Interventions Infectious Diseases & Clinical Care Practice Guidelines Treatments

covid19-sciencetable.ca Last Updated: January 21, 2022